Agimexpharm Pharmaceutical JSC

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000AGP9
VND
39,000.00
500 (1.3%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'21
Sep'21
Jun'21
Mar'21
Dec'20
Sep'20
Jun'20
Net Sales
1,43,576.20
1,27,496.75
1,22,144.51
1,28,582.35
1,33,629.74
1,26,858.09
1,03,488.40
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,43,576.20
1,27,496.75
1,22,144.51
1,28,582.35
1,33,629.74
1,26,858.09
1,03,488.40
Raw Material Cost
88,494.21
85,614.61
79,460.22
84,101.80
87,949.74
86,352.10
69,671.41
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
28,689.22
15,853.31
15,678.08
40,098.10
8,941.12
5,097.28
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
5,900.59
5,159.64
5,334.37
4,232.93
5,440.31
4,916.77
5,004.96
Selling and Distribution Expenses
37,170.83
27,267.32
28,654.67
29,119.59
31,453.35
26,977.01
20,128.10
Other Expenses
-590.06
-3,384.89
-2,118.77
-1,991.10
-4,553.84
-1,385.79
-1,010.22
Total Expenditure (Excl Depreciation)
1,25,665.05
1,12,881.93
1,08,114.89
1,13,221.39
1,19,403.08
1,13,329.10
89,799.51
Operating Profit (PBDIT) excl Other Income
17911.199999999997
14614.8
14029.6
15361
14226.7
13529
13688.900000000001
Other Income
322.50
262.73
402.17
-623.58
383.55
191.75
155.44
Operating Profit (PBDIT)
18,233.65
23,508.11
19,063.10
19,614.04
20,209.90
17,586.21
17,067.18
Interest
5,900.59
5,159.64
5,334.37
4,232.93
5,440.31
4,916.77
5,004.96
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
55,081.98
41,882.14
42,684.29
44,480.55
45,680.00
40,506.00
33,816.99
Depreciation
0.00
8,883.23
4,868.86
4,886.66
5,599.69
3,865.46
3,575.81
Profit Before Tax
12,333.06
9,465.24
8,859.87
10,494.44
9,169.90
8,803.97
8,486.41
Tax
2,193.68
1,893.05
1,771.97
2,098.89
1,763.48
1,760.79
1,697.28
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
10,139.38
7,572.19
7,087.89
8,395.56
7,406.41
7,043.18
6,789.13
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
10,139.38
7,572.19
7,087.89
8,395.56
7,406.41
7,043.18
6,789.13
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
10,139.38
7,572.19
7,087.89
8,395.56
7,406.41
7,043.18
6,789.13
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
Reserves
2,32,229.59
2,21,965.77
2,14,473.67
2,26,164.47
2,17,768.91
2,16,112.25
2,09,437.93
Earnings per share (EPS)
789.97
589.96
552.22
654.11
577.04
548.74
528.95
Diluted Earnings per share
789.97
589.96
552.22
654.11
577.04
548.74
528.95
Operating Profit Margin (Excl OI)
12.48%
11.26%
11.29%
11.94%
10.65%
10.66%
12.89%
Gross Profit Margin
8.59%
14.39%
11.24%
11.96%
11.05%
9.99%
11.66%
PAT Margin
7.06%
5.94%
5.8%
6.53%
5.54%
5.55%
6.56%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Markets Mojo
Analysis not available
Compare Quarterly Results Of Agimexpharm Pharmaceutical JSC With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(VND)
Change(%)
Net Sales
1,43,576.20
0
1,43,576.20
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,43,576.20
0
1,43,576.20
Raw Material Cost
88,494.21
0
88,494.21
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
5,900.59
0
5,900.59
Selling and Distribution Expenses
37,170.83
0
37,170.83
Other Expenses
-590.06
0.00
-590.06
Total Expenditure (Excl Depreciation)
1,25,665.05
0
1,25,665.05
Operating Profit (PBDIT) excl Other Income
17,911.15
0.00
17,911.15
Other Income
322.50
0
322.50
Operating Profit (PBDIT)
18,233.65
0
18,233.65
Interest
5,900.59
0
5,900.59
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
55,081.98
0
55,081.98
Depreciation
0.00
0
0.00
Profit Before Tax
12,333.06
0
12,333.06
Tax
2,193.68
0
2,193.68
Provisions and contingencies
0.00
0
0.00
Profit After Tax
10,139.38
0
10,139.38
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
10,139.38
0
10,139.38
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
10,139.38
0
10,139.38
Equity Capital
0
0
0.00
Face Value
10,000.00
0
0.00
Reserves
2,32,229.59
0
2,32,229.59
Earnings per share (EPS)
789.97
0
789.97
Diluted Earnings per share
789.97
0
789.97
Operating Profit Margin (Excl OI)
12.48%
0%
0.00
12.48%
Gross Profit Margin
8.59%
0%
0.00
8.59%
PAT Margin
7.06%
0%
0.00
7.06%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales NA Million
in

Figures in Million
stock-summary

stock-summary

Quarterly - Standalone Net Profit
Standalone Net Profit NA Million
in

Figures in Million
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) NA Million
in

Figures in Million
Quarterly - Interest
Interest NA Million
in

Figures in Million
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) NA%
in

Figures in %